News Headlines Article

Panel again says Avastin ineffective for breast cancer
USA Today

For the second time, a federal expert panel has decided that the drug Avastin — the top-selling cancer drug in the world — doesn’t help women with advanced breast cancer and may even harm them. A Food and Drug Administration advisory panel voted 6-0 Wednesday to withdraw Avastin’s approval for treatment of breast cancer. The drug remains on the market for now, however, and FDA Commissioner Margaret Hamburg will make the final call.